AN INTRAVENOUS TOXICITY STUDY OF 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN, A USEFUL DRUG SOLUBILIZER, IN RATS AND MONKEYS

被引:115
作者
BREWSTER, ME
ESTES, KS
BODOR, N
机构
[1] PHARMATEC INC, ALACHUA, FL 32615 USA
[2] UNIV FLORIDA, COLL PHARM, CTR DRUG DESIGN & DELIVERY, GAINESVILLE, FL 32610 USA
关键词
2-Hydroxypropyl-β-cyclodextrin; Inclusion complex; Nephrosis; Toxicity; β-Cyclodextrin;
D O I
10.1016/0378-5173(90)90114-J
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The subacute and subchronic intravenous (i.v.) toxicity of 2-hydroxypropyl-β-cyclodextrin (HPCD) was examined in Sprague-Dawley rats and cynomolgus monkeys. After either 14 or 90 days of alternate day dosing with either saline or 200 mg/kg HPCD, no toxicologically meaningful differences were observed in the following parameters: body weight, body weight gain, food consumption, hematology, clinical chemistry, organ weights, organ to brain weight ratio, organ to body weight ratio and macroscopic and microscopic histopathology. Subsequent to these studies, an acute high-dose study was performed in cynomolgus monkeys which indicated that a single i.v. dose of HPCD as high as 10 g/kg was not lethal. © 1990.
引用
收藏
页码:231 / 243
页数:13
相关论文
共 22 条
[1]  
Anderson W R, 1988, Drug Des Deliv, V2, P287
[2]   IMPROVED DELIVERY THROUGH BIOLOGICAL-MEMBRANES .31. SOLUBILIZATION AND STABILIZATION OF AN ESTRADIOL CHEMICAL DELIVERY SYSTEM BY MODIFIED BETA-CYCLODEXTRINS [J].
BREWSTER, ME ;
ESTES, KS ;
LOFTSSON, T ;
PERCHALSKI, R ;
DERENDORF, H ;
MULLERSMAN, G ;
BODOR, N .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (11) :981-985
[3]   SEVERE HYPERVITAMINOSIS A IN SIBLINGS - EVIDENCE OF VARIABLE TOLERANCE TO RETINOL INTAKE [J].
CARPENTER, TO ;
PETTIFOR, JM ;
RUSSELL, RM ;
PITHA, J ;
MOBARHAN, S ;
OSSIP, MS ;
WAINER, S ;
ANAST, CS .
JOURNAL OF PEDIATRICS, 1987, 111 (04) :507-512
[4]   LIPID EMULSIONS AS DRUG DELIVERY SYSTEMS [J].
DAVIS, SS ;
WASHINGTON, C ;
WEST, P ;
ILLUM, L ;
LIVERSIDGE, G ;
STERNSON, L ;
KIRSH, R .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 507 :75-88
[5]  
Davis SS, 1986, SITE SPECIFIC DRUG D, P93
[6]  
FRANK DW, 1976, AM J PATHOL, V83, P367
[7]  
HIASA Y, 1981, Journal of Nara Medical Association, V32, P316
[8]   DRUG DELIVERY TO MACROPHAGES FOR THE THERAPY OF CANCER AND INFECTIOUS-DISEASES [J].
KIRSH, R ;
BUGELSKI, PJ ;
POSTE, G .
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 507 :141-154
[9]  
Levene, 1961, CONTRIBUTIONS PROBAB, P279, DOI DOI 10.1137/1003016
[10]  
Matsuda K., 1983, OYO YAKURI, V26, P287